Pharmaceutical company’s stock price move diverges from rival Merck as both groups bolster new treatment pipelines
Pfizer shares dip as vaccines continue to weigh on sales
Recent Posts
- Citadel’s Ken Griffin says Trump White House has ‘enriched’ family members
- Texas Instruments in advanced talks to buy chip designer Silicon Labs
- Warsh faces Senate battle as lawmakers object to Trump’s attacks on Fed
- Pfizer shares dip as vaccines continue to weigh on sales
- Novo Nordisk warns sales could slide 13% as obesity competition mounts
